Comparative Effectiveness of Gemcitabine plus Nab-Paclitaxel and FOLFIRINOX in the First-Line Setting of Metastatic Pancreatic Cancer: A Systematic Review and Meta-Analysis

Gemcitabine and nab-paclitaxel (GEM-NAB) and the combination of 5-fluorouracil, oxaliplatin, and irinotecan (FOLFIRINOX) are valid first-line options for advanced or metastatic pancreatic cancer (mPC). However, no randomized trials comparing the two schemes have been performed. This meta-analysis ai...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancers (Basel)
Main Authors: Pusceddu, Sara, Ghidini, Michele, Torchio, Martina, Corti, Francesca, Tomasello, Gianluca, Niger, Monica, Prinzi, Natalie, Nichetti, Federico, Coinu, Andrea, Di Bartolomeo, Maria, Cabiddu, Mary, Passalacqua, Rodolfo, de Braud, Filippo, Petrelli, Fausto
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2019
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6520876/
https://ncbi.nlm.nih.gov/pubmed/30959763
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11040484
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados